Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	Hepatology 2012 (546 pages, free PDF) Hepatitis C 2012 (150 pages, free PDF)	Free Medical Books

Peptic Ulcer

Free Subscription Articles published in Aliment Pharmacol Ther Retrieve available abstracts of 99 articles: HTML format Text format

Single Articles

May 2012
1. MUSUMBA C , Jorgensen A, Sutton L, Van Eker D, et al
   The relative contribution of NSAIDs and H elicobacter pylori to the aetiology of endoscopically-diagnosed peptic ulcer disease: observations from a tertiary referral hospital in the UK between 2005 and 2010.
   Aliment Pharmacol Ther. 2012 May 3. doi: 10.1111/j.1365-2036.2012.05118.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   April 2012
2. BRUNNER G , Athmann C, Schneider A
   Long-term, open-label trial: safety and efficacy of continuous maintenance treatment with pantoprazole for up to 15 years in severe acid-peptic disease.
   Aliment Pharmacol Ther. 2012 Apr 24. doi: 10.1111/j.1365-2036.2012.05106.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. GENTA RM , Sonnenberg A
   Non-Helicobacter pylori gastritis is common among paediatric patients with inflammatory bowel disease.
   Aliment Pharmacol Ther. 2012 Apr 9. doi: 10.1111/j.1365-2036.2012.05090.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. TACK J , Becher A, Mulligan C, Johnson DA, et al
   Systematic review: the burden of disruptive gastro-oesophageal reflux disease on health-related quality of life.
   Aliment Pharmacol Ther. 2012 Apr 8. doi: 10.1111/j.1365-2036.2012.05086.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. MONNIKES H , Schwan T, van Rensburg C, Straszak A, et al
   Randomised clinical trial: sustained response to PPI treatment of symptoms resembling functional dyspepsia and irritable bowel syndrome in patients suffering from an overlap with erosive gastro-oesophageal reflux disease.
   Aliment Pharmacol Ther. 2012 Apr 8. doi: 10.1111/j.1365-2036.2012.05085.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. MCNULTY CA , Lasseter G, Shaw I, Nichols T, et al
   Is Helicobacter pylori antibiotic resistance surveillance needed and how can it be delivered?
   Aliment Pharmacol Ther. 2012 Apr 2. doi: 10.1111/j.1365-2036.2012.05083.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   March 2012
7. KESSING BF , Bredenoord AJ, Velosa M, Smout AJ, et al
   Supragastric belches are the main determinants of troublesome belching symptoms in patients with gastro-oesophageal reflux disease.
   Aliment Pharmacol Ther. 2012 Mar 20. doi: 10.1111/j.1365-2036.2012.05070.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. COSSENTINO MJ , Mann K, Armbruster SP, Lake JM, et al
   Randomised clinical trial: the effect of baclofen in patients with gastro-oesophageal reflux - a randomised prospective study.
   Aliment Pharmacol Ther. 2012 Mar 20. doi: 10.1111/j.1365-2036.2012.05068.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. PACIFICO L , Osborn JF, Anania C, Vaira D, et al
   Review article: bismuth-based therapy for Helicobacter pylori eradication in children.
   Aliment Pharmacol Ther. 2012 Mar 8. doi: 10.1111/j.1365-2036.2012.05055.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. GOH KL , Manikam J, Qua CS
    High-dose rabeprazole-amoxicillin dual therapy and rabeprazole triple therapy with amoxicillin and levofloxacin for 2 weeks as first and second line rescue therapies for Helicobacter pylori treatment failures.
    Aliment Pharmacol Ther. 2012 Mar 8. doi: 10.1111/j.1365-2036.2012.05054.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2012
11. GISBERT JP , Castro-Fernandez M, Perez-Aisa A, Cosme A, et al
    Fourth-line rescue therapy with rifabutin in patients with three Helicobacter pylori eradication failures.
    Aliment Pharmacol Ther. 2012 Feb 28. doi: 10.1111/j.1365-2036.2012.05053.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. CHEN CC , Lee JY, Fang YJ, Hsu SJ, et al
    Randomised clinical trial: high-dose vs. standard-dose proton pump inhibitors for the prevention of recurrent haemorrhage after combined endoscopic haemostasis of bleeding peptic ulcers.
    Aliment Pharmacol Ther. 2012 Feb 28. doi: 10.1111/j.1365-2036.2012.05047.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. GERSON LB , Mitra S, Bleker WF, Yeung P, et al
    Control of intra-oesophageal pH in patients with Barrett's oesophagus on omeprazole-sodium bicarbonate therapy.
    Aliment Pharmacol Ther. 2012 Feb 22. doi: 10.1111/j.1365-2036.2012.05016.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. HUANG KW , Luo JC, Leu HB, Lin HC, et al
    Chronic obstructive pulmonary disease: an independent risk factor for peptic ulcer bleeding: a nationwide population-based study.
    Aliment Pharmacol Ther. 2012 Feb 21. doi: 10.1111/j.1365-2036.2012.05028.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. HUNFELD NG , Touw DJ, Mathot RA, van Schaik RH, et al
    A comparison of the acid-inhibitory effects of esomeprazole and rabeprazole in relation to pharmacokinetics and CYP2C19 polymorphism.
    Aliment Pharmacol Ther. 2012 Feb 13. doi: 10.1111/j.1365-2036.2012.05014.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. DALL M , Depont Christensen R, Schaffalitzky de Muckadell OB, Lassen AT, et al
    Re-prescribing of causative drugs in persons discharged after serious drug-induced upper gastrointestinal bleeding.
    Aliment Pharmacol Ther. 2012 Feb 7. doi: 10.1111/j.1365-2036.2012.05006.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2012
17. SONNENBERG A , Genta RM
    Low prevalence of Helicobacter pylori infection among patients with inflammatory bowel disease.
    Aliment Pharmacol Ther. 2012 Jan 5. doi: 10.1111/j.1365-2036.2011.04969.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2011
18. HASSALL E , Shepherd R, Koletzko S, Radke M, et al
    Long-term maintenance treatment with omeprazole in children with healed erosive oesophagitis: a prospective study.
    Aliment Pharmacol Ther. 2011 Dec 18. doi: 10.1111/j.1365-2036.2011.04950.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2011
19. GISBERT JP , Calvet X
    Review article: rifabutin in the treatment of refractory Helicobacter pylori infection.
    Aliment Pharmacol Ther. 2011 Nov 30. doi: 10.1111/j.1365-2036.2011.04937.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. MALFERTHEINER P , Nocon M, Vieth M, Stolte M, et al
    Evolution of gastro-oesophageal reflux disease over 5 years under routine medical care - the ProGERD study.
    Aliment Pharmacol Ther. 2011 Nov 9. doi: 10.1111/j.1365-2036.2011.04901.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. PARK HG , Jung MK, Jung JT, Kwon JG, et al
    Randomised clinical trial: comparative study of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori infection in naive patients.
    Aliment Pharmacol Ther. 2011 Nov 8. doi: 10.1111/j.1365-2036.2011.04902.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. SCHMIDT M , Johansen MB, Robertson DJ, Maeng M, et al
    Concomitant use of clopidogrel and proton pump inhibitors is not associated with major adverse cardiovascular events following coronary stent implantation.
    Aliment Pharmacol Ther. 2011 Nov 4. doi: 10.1111/j.1365-2036.2011.04890.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
23. GISBERT JP , Calvet X
    Review article: the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade, but it is not good enough.
    Aliment Pharmacol Ther. 2011 Oct 21. doi: 10.1111/j.1365-2036.2011.04887.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. BAVISHI C , Dupont HL
    Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection.
    Aliment Pharmacol Ther. 2011 Oct 17. doi: 10.1111/j.1365-2036.2011.04874.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. HERSHCOVICI T , Jha LK, Johnson T, Gerson L, et al
    Systematic review: the relationship between interstitial lung diseases and gastro-oesophageal reflux disease.
    Aliment Pharmacol Ther. 2011 Oct 17. doi: 10.1111/j.1365-2036.2011.04870.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. GOH KL , Mahadeva S, Ho SH
    Erosive oesophagitis with particular reference to Asians.
    Aliment Pharmacol Ther. 2011;34:821-2.
    PubMed     Text format     Related articles   
    
    
    
    September 2011
27. KIM YS , Kim SJ, Yoon JH, Suk KT, et al
    Randomised clinical trial: the efficacy of a 10-day sequential therapy vs. a 14-day standard proton pump inhibitor-based triple therapy for Helicobacter pylori in Korea.
    Aliment Pharmacol Ther. 2011 Sep 19. doi: 10.1111/j.1365-2036.2011.04843.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. GARCIA-IGLESIAS P , Villoria A, Suarez D, Brullet E, et al
    Meta-analysis: predictors of rebleeding after endoscopic treatment for bleeding peptic ulcer.
    Aliment Pharmacol Ther. 2011 Sep 7. doi: 10.1111/j.1365-2036.2011.04830.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
29. VELDHUYZEN VAN ZANTEN S , Wahlqvist P, Talley NJ, Halling K, et al
    Randomised clinical trial: the burden of illness of uninvestigated dyspepsia before and after treatment with esomeprazole - results from the STARS II study.
    Aliment Pharmacol Ther. 2011 Aug 17. doi: 10.1111/j.1365-2036.2011.04789.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. HSU CS , Wang PC, Chen JH, Su WC, et al
    Increasing insulin resistance is associated with increased severity and prevalence of gastro-oesophageal reflux disease.
    Aliment Pharmacol Ther. 2011 Aug 17. doi: 10.1111/j.1365-2036.2011.04817.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
31. BECHER A , El-Serag H
    Systematic review: the association between symptomatic response to proton pump inhibitors and health-related quality of life in patients with gastro-oesophageal reflux disease.
    Aliment Pharmacol Ther. 2011 Jul 20. doi: 10.1111/j.1365-2036.2011.04774.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. RAVI K , Francis DL, See JA, Geno DM, et al
    The effects of a weakly acidic meal on gastric buffering and postprandial gastro-oesophageal reflux.
    Aliment Pharmacol Ther. 2011 Jul 5. doi: 10.1111/j.1365-2036.2011.04761.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. LUO JC , Huang KW, Leu HB, Chen LC, et al
    Randomised clinical trial: rabeprazole plus aspirin is not inferior to rabeprazole plus clopidogrel for the healing of aspirin-related peptic ulcer.
    Aliment Pharmacol Ther. 2011 Jul 5. doi: 10.1111/j.1365-2036.2011.04760.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. CHACKO Y , Holtmann GJ
    Helicobacter pylori eradication and weight gain: has it opened a Pandora's box?
    Aliment Pharmacol Ther. 2011;34:256.
    PubMed     Text format     Related articles   
    
    
    
    June 2011
35. GERSON LB , Bonafede M, Princic N, Gregory C, et al
    Development of a refractory gastro-oesophageal reflux score using an administrative claims database.
    Aliment Pharmacol Ther. 2011 Jun 30. doi: 10.1111/j.1365-2036.2011.04755.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. CHAVEZ-TAPIA NC , Barrientos-Gutierrez T, Tellez-Avila F, Soares-Weiser K, et al
    Meta-analysis: antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding - an updated Cochrane review.
    Aliment Pharmacol Ther. 2011 Jun 27. doi: 10.1111/j.1365-2036.2011.04746.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. SHARMA P , Johnson DA, Monyak JT, Illueca M, et al
    Race affects healing of erosive oesophagitis in patients treated with proton pump inhibitors.
    Aliment Pharmacol Ther. 2011 Jun 20. doi: 10.1111/j.1365-2036.2011.04736.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. SAVARINO E , Gemignani L, Pohl D, Zentilin P, et al
    Oesophageal motility and bolus transit abnormalities increase in parallel with the severity of gastro-oesophageal reflux disease.
    Aliment Pharmacol Ther. 2011 Jun 14. doi: 10.1111/j.1365-2036.2011.04742.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
39. MCQUAID KR , Laine L, Fennerty MB, Souza R, et al
    Systematic review: the role of bile acids in the pathogenesis of gastro-oesophageal reflux disease and related neoplasia.
    Aliment Pharmacol Ther. 2011 May 25. doi: 10.1111/j.1365-2036.2011.04709.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. BAI Y , Guo JF, Li ZS
    Meta-analysis: erythromycin before endoscopy for acute upper gastrointestinal bleeding.
    Aliment Pharmacol Ther. 2011 May 25. doi: 10.1111/j.1365-2036.2011.04708.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. SAINI SD , Fendrick AM, Scheiman JM
    Cost-effectiveness analysis: cardiovascular benefits of proton pump inhibitor co-therapy in patients using aspirin for secondary prevention.
    Aliment Pharmacol Ther. 2011 May 25. doi: 10.1111/j.1365-2036.2011.04707.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. MORELLI G , Chen H, Rossiter G, Rege B, et al
    Rabeprazole extended-release 50 mg compared with esomeprazole 40 mg and rabeprazole delayed release 20 mg: authors' reply.
    Aliment Pharmacol Ther. 2011;33:1179-1180.
    PubMed     Text format     Related articles   
    
    
    
    
43. YUAN Y , Hunt RH
    Rabeprazole extended-release 50 mg compared with esomeprazole 40 mg and rabeprazole delayed release 20 mg.
    Aliment Pharmacol Ther. 2011;33:1177-1179.
    PubMed     Text format     Related articles   
    
    
    
    April 2011
44. LANAS A , Aabakken L, Fonseca J, Mungan ZA, et al
    Clinical predictors of poor outcomes among patients with nonvariceal upper gastrointestinal bleeding in Europe.
    Aliment Pharmacol Ther. 2011 Apr 11. doi: 10.1111/j.1365-2036.2011.04651.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
45. DE BORTOLI N , Martinucci I, Piaggi P, Maltinti S, et al
    Randomised clinical trial: twice daily esomeprazole 40 mg vs. pantoprazole 40 mg in Barrett's oesophagus for 1 year.
    Aliment Pharmacol Ther. 2011 Mar 8. doi: 10.1111/j.1365-2036.2011.04616.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. LANE JA , Murray LJ, Harvey IM, Donovan JL, et al
    Randomised clinical trial: Helicobacter pylori eradication is associated with a significantly increased body mass index in a placebo-controlled study.
    Aliment Pharmacol Ther. 2011 Mar 2. doi: 10.1111/j.1365-2036.2011.04610.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
47. ZERBIB F , Bruley des Varannes S, Roman S, Tutuian R, et al
    Randomised clinical trial: effects of monotherapy with ADX10059, a mGluR5 inhibitor, on symptoms and reflux events in patients with gastro-oesophageal reflux disease.
    Aliment Pharmacol Ther. 2011 Feb 14. doi: 10.1111/j.1365-2036.2011.04596.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. HASSALL E , Owen D, Kerr W, Sturby T, et al
    Gastric histology in children treated with proton pump inhibitors long term, with emphasis on enterochromaffin cell-like hyperplasia.
    Aliment Pharmacol Ther. 2011 Feb 14. doi: 10.1111/j.1365-2036.2011.04592.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. DISNEY BR , Watson RD, Blann AD, Lip GY, et al
    Review article: proton pump inhibitors with clopidogrel - evidence for and against a clinically-important interaction.
    Aliment Pharmacol Ther. 2011 Feb 8. doi: 10.1111/j.1365-2036.2011.04585.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
50. MORELLI G , Chen H, Rossiter G, Rege B, et al
    An open-label, parallel, multiple-dose study comparing the pharmacokinetics and gastric acid suppression of rabeprazole extended-release with esomeprazole 40 mg and rabeprazole delayed-release 20 mg in healthy volunteers.
    Aliment Pharmacol Ther. 2011 Jan 28. doi: 10.1111/j.1365-2036.2011.04580.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. HERSHCOVICI T , Jha LK, Cui H, Powers J, et al
    Night-time intra-oesophageal bile and acid: a comparison between gastro-oesophageal reflux disease patients who failed and those who were treated successfully with a proton pump inhibitor.
    Aliment Pharmacol Ther. 2011 Jan 25. doi: 10.1111/j.1365-2036.2011.04583.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. KESSING BF , Conchillo JM, Bredenoord AJ, Smout AJ, et al
    Review article: the clinical relevance of transient lower oesophageal sphincter relaxations in gastro-oesophageal reflux disease.
    Aliment Pharmacol Ther. 2011 Jan 10. doi: 10.1111/j.1365-2036.2010.04565.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. AHSBERG K , Ye W, Lu Y, Zheng Z, et al
    Hospitalisation of and mortality from bleeding peptic ulcer in Sweden: a nationwide time-trend analysis.
    Aliment Pharmacol Ther. 2011 Jan 6. doi: 10.1111/j.1365-2036.2010.04562.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
54. KUNSCH S , Gross V, Neesse A, Sohrabi K, et al
    Combined lung-sound and reflux-monitoring: a pilot study of a novel approach to detect nocturnal respiratory symptoms in gastro-oesophageal reflux disease.
    Aliment Pharmacol Ther. 2011 Jan 4. doi: 10.1111/j.1365-2036.2010.04559.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. BUTTON LA , Roberts SE, Evans PA, Goldacre MJ, et al
    Hospitalized incidence and case fatality for upper gastrointestinal bleeding from 1999 to 2007: a record linkage study.
    Aliment Pharmacol Ther. 2011;33:64-76.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
56. FRAZZONI M , Conigliaro R, Melotti G
    Weakly acidic refluxes have a major role in the pathogenesis of proton pump inhibitor-resistant reflux oesophagitis.
    Aliment Pharmacol Ther. 2010 Dec 29. doi: 10.1111/j.1365-2036.2010.04550.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
57. MIEHLKE S , Lobe S, Madisch A, Kuhlisch E, et al
    Intragastric acidity during administration of generic omeprazole or esomeprazole - a randomised, two-way crossover study including CYP2C19 genotyping.
    Aliment Pharmacol Ther. 2010 Dec 22. doi: 10.1111/j.1365-2036.2010.04544.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. CORVAGLIA L , Aceti A, Mariani E, De Giorgi M, et al
    The efficacy of sodium alginate (Gaviscon) for the treatment of gastro-oesophageal reflux in preterm infants.
    Aliment Pharmacol Ther. 2010 Dec 15. doi: 10.1111/j.1365-2036.2010.04545.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
59. BECHER A , Dent J
    Systematic review: ageing and gastro-oesophageal reflux disease symptoms, oesophageal function and reflux oesophagitis.
    Aliment Pharmacol Ther. 2010 Dec 8. doi: 10.1111/j.1365-2036.2010.04542.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
60. DALL M , Schaffalitzky de Muckadell OB, Lassen AT, Hallas J, et al
    There is an association between selective serotonin reuptake inhibitor use and uncomplicated peptic ulcers: a population-based case-control study.
    Aliment Pharmacol Ther. 2010;32.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
61. MIWA H , Inoue K, Ashida K, Kogawa T, et al
    Randomised clinical trial: efficacy of the addition of a prokinetic, mosapride citrate, to omeprazole in the treatment of patients with non-erosive reflux disease - a double-blind, placebo-controlled study.
    Aliment Pharmacol Ther. 2010 Dec 1. doi: 10.1111/j.1365-2036.2010.04517.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
62. DABHOLKAR AH , Han C, Paris MM, Perez MC, et al
    The 12-month safety profile of dexlansoprazole, a proton pump inhibitor with a dual delayed release formulation, in patients with gastro-oesophageal reflux disease.
    Aliment Pharmacol Ther. 2010 Nov 30. doi: 10.1111/j.1365-2036.2010.04519.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
63. LAINE L , Katz PO, Johnson DA, Ibegbu I, et al
    Randomised clinical trial: a novel rabeprazole extended release 50 mg formulation vs. esomeprazole 40 mg in healing of moderate-to-severe erosive oesophagitis - the results of two double-blind studies.
    Aliment Pharmacol Ther. 2010 Nov 30. doi: 10.1111/j.1365-2036.2010.04516.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
64. GADDAM S , Wani S, Ahmed H, Maddur P, et al
    The impact of pre-endoscopy proton pump inhibitor use on the classification of non-erosive reflux disease and erosive oesophagitis.
    Aliment Pharmacol Ther. 2010;32:1266-74.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
65. WILDER-SMITH C , Rohss K, Bokelund Singh S, Sagar M, et al
    The effects of dose and timing of esomeprazole administration on 24-h, daytime and night-time acid inhibition in healthy volunteers.
    Aliment Pharmacol Ther. 2010;32:1249-56.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
66. RUBENSTEIN JH , Taylor JB
    Meta-analysis: the association of oesophageal adenocarcinoma with symptoms of gastro-oesophageal reflux.
    Aliment Pharmacol Ther. 2010;32:1222-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
67. KESZTHELYI D , Jansen SV, Schouten GA, De Kort S, et al
    Proton pump inhibitor use is associated with an increased risk for microscopic colitis: a case-control study.
    Aliment Pharmacol Ther. 2010;32:1124-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
68. SZAJEWSKA H , Horvath A, Piwowarczyk A
    Meta-analysis: the effects of Saccharomyces boulardii supplementation on Helicobacter pylori eradication rates and side effects during treatment.
    Aliment Pharmacol Ther. 2010;32:1069-79.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
69. GOLDSTEIN JL , Jungwirthova A, David J, Spindel E, et al
    Clinical trial: endoscopic evaluation of naproxen etemesil, a naproxen prodrug, vs. naproxen - a proof-of-concept, randomized, double-blind, active-comparator study.
    Aliment Pharmacol Ther. 2010;32:1091-101.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
70. MEINECHE-SCHMIDT V , Christensen E, Bytzer P
    Randomised clinical trial: identification of responders to short-term treatment with esomeprazole for dyspepsia in primary care - a randomised, placebo-controlled study.
    Aliment Pharmacol Ther. 2010 Oct 29. doi: 10.1111/j.1365-2036.2010.04501.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
71. VALKHOFF VE , 't Jong GW, Van Soest EM, Kuipers EJ, et al
    Risk of recurrent myocardial infarction with the concomitant use of clopidogrel and proton pump inhibitors.
    Aliment Pharmacol Ther. 2010 Oct 19. doi: 10.1111/j.1365-2036.2010.04485.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
72. ABU-SNEINEH A , Tam W, Schoeman M, Fraser R, et al
    The effects of high-dose esomeprazole on gastric and oesophageal acid exposure and molecular markers in Barrett's oesophagus.
    Aliment Pharmacol Ther. 2010;32:1023-30.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
73. VAEZI MF , Slaughter JC, Smith BS, Washington MK, et al
    Dilated intercellular space in chronic laryngitis and gastro-oesophageal reflux disease: at baseline and post-lansoprazole therapy.
    Aliment Pharmacol Ther. 2010 Aug 2. doi: 10.1111/j.1365-2036.2010.04420.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
74. MOLINA-INFANTE J , Gisbert JP
    One size does not fit all - time to regionalize Helicobacter pylori eradication? authors' reply.
    Aliment Pharmacol Ther. 2010;32:507-8.
    PubMed     Text format     Related articles   
    
    
    
    
75. TAN VP , Wong BC
    One size does not fit all - time to regionalize Helicobacter pylori eradication?
    Aliment Pharmacol Ther. 2010;32:506-7.
    PubMed     Text format     Related articles   
    
    
    
    July 2010
76. FLETCHER EH , Johnston DE, Fisher CR, Koerner RJ, et al
    Systematic review: Helicobacter pylori and upper gastrointestinal bleeding risk in patients taking aspirin.
    Aliment Pharmacol Ther. 2010 Jul 26. doi: 10.1111/j.1365-2036.2010.04415.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
77. SONNENBERG A , Baron JH
    Rising trends of gastric cancer and peptic ulcer in the 19th century.
    Aliment Pharmacol Ther. 2010 Jul 26. doi: 10.1111/j.1365-2036.2010.04413.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
78. EL-SERAG H , Becher A, Jones R
    Systematic review: persistent reflux symptoms on proton pump inhibitor therapy in primary care and community studies.
    Aliment Pharmacol Ther. 2010 Jul 20. doi: 10.1111/j.1365-2036.2010.04406.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
79. YUEN E , Romney M, Toner RW, Cobb NM, et al
    Prevalence, knowledge and care patterns for gastro-oesophageal reflux disease in United States minority populations.
    Aliment Pharmacol Ther. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
80. AHSBERG K , Hoglund P, Stael von Holstein C
    Mortality from peptic ulcer bleeding: the impact of comorbidity and the use of drugs that promote bleeding.
    Aliment Pharmacol Ther. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
81. FASS R
    Patients vote with their feet for 'On demand' rabeprazole in the maintenance treatment phase of reflux oesophagitis: author's reply.
    Aliment Pharmacol Ther. 2010;32:307-8.
    PubMed     Text format     Related articles   
    
    
    
    
82. TAN VP , Wong BC
    Patients vote with their feet for 'On demand' rabeprazole in the maintenance treatment phase of reflux oesophagitis.
    Aliment Pharmacol Ther. 2010;32:305-7.
    PubMed     Text format     Related articles   
    
    
    
    June 2010
83. SPIEGEL BM , Roberts L, Mody R, Harding G, et al
    Development and validation of a nocturnal gastro-oesophageal reflux disease symptom severity and impact questionnaire (N-GSSIQ) for adults.
    Aliment Pharmacol Ther. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2010
84. CALABRESE C , Spisni E, Liguori G, Lazzarini G, et al
    Potential role of the cannabinoid receptor CB1 in the pathogenesis of erosive and non-erosive gastro-oesophageal reflux disease.
    Aliment Pharmacol Ther. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
85. GOLDSTEIN JL , Hochberg MC, Fort JG, Zhang Y, et al
    Clinical trial: incidence of NSAID-associated endoscopic gastric ulcers in patients treated with PN 400 (naproxen plus esomeprazole magnesium) vs. enteric-coated naproxen alone.
    Aliment Pharmacol Ther. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
86. BOECKXSTAENS GE , Smout A
    Systematic review: role of acid, weakly acidic and weakly alkaline reflux in gastroesophageal reflux disease.
    Aliment Pharmacol Ther. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
87. MINER JR P , Plachetka J, Orlemans E, Fort JG, et al
    Clinical trial: evaluation of gastric acid suppression with three doses of immediate-release esomeprazole in the fixed-dose combination of PN 400 (naproxen / esomeprazole magnesium) compared with naproxen 500 mg and enteric-coated esomeprazole 20 mg -
    Aliment Pharmacol Ther. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
88. HARVEY RF , Lane JA, Nair P, Egger M, et al
    Clinical trial: the prolonged beneficial effect of Helicobacter pylori eradication on dyspepsia consultations - the Bristol Helicobacter Project.
    Aliment Pharmacol Ther. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
89. HEARNSHAW SA , Logan RF, Palmer KR, Card TR, et al
    Outcomes following early red blood cell transfusion in acute upper gastrointestinal bleeding.
    Aliment Pharmacol Ther. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2010
90. JOHNSON D , Crawley JA, Hwang C, Brown K, et al
    Clinical trial: esomeprazole for moderate to severe nighttime heartburn and gastroesophageal reflux disease-related sleep disturbances.
    Aliment Pharmacol Ther. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
91. TALWAR V , Wurm P, Bankart MJ, Gershlick AH, et al
    Clinical trial: chest pain due to presumed gastro-oesophageal reflux in coronary artery disease - controlled study of lansoprazole versus placebo.
    Aliment Pharmacol Ther. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
92. MORGAN D , Pandolfino J, Katz PO, Goldstein JL, et al
    Clinical trial: gastric acid suppression in Hispanic adults with symptomatic gastroesophageal reflux disease - comparator study of esomeprazole, lansoprazole, and pantoprazole.
    Aliment Pharmacol Ther. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
93. THUKKANI N , Sonnenberg A
    The influence of environmental risk factors in hospitalization for gastro-oesophageal reflux disease-related diagnoses in the United States.
    Aliment Pharmacol Ther. 2010;31:852-61.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2010
94. CREMONINI F , Ziogas D, Chang HY, Kokkotou E, et al
    Meta-analysis: the effects of placebo treatment on gastro-oesophageal reflux disease.
    Aliment Pharmacol Ther. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
95. HABER MM , Hunt B, Freston JW, Peura DA, et al
    Gastric histology changes in patients with erosive esophagitis receiving long-term lansoprazole maintenance therapy.
    Aliment Pharmacol Ther. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
96. CAMERON C , VAN Zanten SV, Skedgel C, Flowerdew G, et al
    Cost-utility analysis of proton pump inhibitors and other gastro-protective agents for prevention of gastrointestinal complications in elderly patients taking non-selective non-steroidal anti-inflammatory agents.
    Aliment Pharmacol Ther. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
97. JOHNSTONE J , Nerenberg K, Loeb M
    Meta-analysis: proton pump inhibitor use and risk of community acquired pneumonia.
    Aliment Pharmacol Ther. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2010
98. HART J , Hawkey CJ, Lanas A, Naesdal J, et al
    Predictors of gastroduodenal erosions in patients taking low-dose aspirin.
    Aliment Pharmacol Ther. 2010;31:143-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2009
99. VAN VLIET EP , Steyerberg EW, Otten HJ, Rudolphus A, et al
    The effects of guideline implementation for proton pump inhibitor prescription on two pulmonary medicine wards.
    Aliment Pharmacol Ther. 2009;29:213-21.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: